Patents Assigned to Hankook Pharm. Co., Inc.
  • Patent number: 8206760
    Abstract: Disclosed is a composition for the inhibition of transplant rejection and the treatment of skin diseases, comprising a cordyceps mycellia extract as an active ingredient. The cordyceps mycellia extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change. Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation. Also, it stops oozing from sores and is useful in the treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, pemphigus and smallpox.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: June 26, 2012
    Assignee: Hankook Pharm. Co., Inc.
    Inventors: Man Woo Han, Jae Kuk Yoo, Chang-Uk Hur, Hwan-Chul Kim, Jin Pyo Kim
  • Publication number: 20110243970
    Abstract: Disclosed is a composition for the inhibition of transplant rejection and the treatment of skin diseases, comprising a cordyceps mycellia extract as an active ingredient. The cordyceps mycellia extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change. Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation. Also, it stops oozing from sores and is useful in the treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, pemphigus and smallpox.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 6, 2011
    Applicant: HANKOOK PHARM. CO., INC.
    Inventors: Man Woo HAN, Jae Kuk YOO, Chang-Uk HUR, Hwan-Chul KIM, Jin Pyo KIM
  • Publication number: 20100291154
    Abstract: Disclosed is a composition for the inhibition of transplant rejection and the prevention and treatment of skin diseases, comprising a cordyceps mycellia extract as an active ingredient. The cordyceps mycellia extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change. Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation. Also, it stops oozing from sores and is useful in the prevention and treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, pemphigus and smallpox.
    Type: Application
    Filed: December 7, 2007
    Publication date: November 18, 2010
    Applicant: HANKOOK PHARM. CO., INC.
    Inventors: Man Woo Han, Jae Kuk Yoo, Chang-Uk Hur, Hwan-Chul Kim, Jin Pyo Kim
  • Publication number: 20100255024
    Abstract: Disclosed is a composition for the inhibition of transplant rejection and the prevention and treatment of skin diseases, comprising a Phellinus sp. mycelial extract as an active ingredient. The Phellinus sp. mycelial extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change. Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation. Also, it stops oozing from sores and is applicable to the prevention and treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, and smallpox.
    Type: Application
    Filed: December 7, 2007
    Publication date: October 7, 2010
    Applicant: HANKOOK PHARM. CO., INC.
    Inventors: Man Woo Han, Jae Kuk Yoo, Chang-Uk Hur, Hwan-Chul Kim, Jin Pyo Kim
  • Patent number: 7763287
    Abstract: The present invention relates to extract of Cercis chinensis having anti-oxidant activity and anti-aging activity containing compound of chemical formula 1 to chemical formula 20, and cosmetical composition for anti-oxidation, skin-aging protection and wrinkle improvement containing the extract as effective ingredient. The extract of present invention having protective effect on oxidative damage and skin damage, and inhibitory effect on age-dependent telomere shortening, so it can effectively used as skin-aging protection cosmetic.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: July 27, 2010
    Assignees: Hankook Pharm. Co., Inc., Hansaeng Cosmetic Co., Ltd.
    Inventors: Min Kyun Na, Jae-Kuk Yoo, Chan Bog Lee, Jin Pyo Kim, Gon Hyeok Lim, Dong Il Min, Young Min Jeon
  • Publication number: 20080187610
    Abstract: The present invention relates to extract of Cercis chinensis having anti-oxidant activity and anti aging activity containing compound of chemical formula 1 to chemical formula 20, and cosmetical composition for anti-oxidation, skin-aging protection and wrinkle improvement containing the extract as effective ingredient. The extract of present invention having protective effect on oxidative damage and skin damage, and inhibitory effect on age-dependent telomere shortening, so it can effectively used as skin-aging protection cosmetic.
    Type: Application
    Filed: February 15, 2008
    Publication date: August 7, 2008
    Applicants: HANKOOK PHARM. CO., INC., HANSAENG COSMETIC CO., LTD.
    Inventors: Min Kyun NA, Jae-Kuk YOO, Chan Bog LEE, Jin Pyo KIM, Gon Hyeok LIM, Dong Il MIN, Young Min JEON